SpyGlass Ophthalmics

SpyGlass Ophthalmics focuses on developing new therapies for chronic ophthalmic diseases. Our team consists of engineers, scientists, and clinicians who are deeply rooted in ophthalmic devices and drug delivery. We have been preparing for regulatory approval from the very beginning. We have active projects aimed at addressing unmet needs in cataract/lens replacement surgery and other chronic ophthalmic conditions. We value partnerships that can lead to a global shift in eye care paradigms.